Condition
Squamous Cell Cancer of the Head and Neck
Total Trials
4
Recruiting
0
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
P 1 (3)
P 2 (1)
Trial Status
Active Not Recruiting2
Not Yet Recruiting1
Withdrawn1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07460765Phase 1Not Yet Recruiting
Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT05651022Phase 1Active Not Recruiting
Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors
NCT05057013Phase 1Active Not Recruiting
A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours
NCT00934518Phase 2WithdrawnPrimary
Image Guided Intensity Modulated Reirradiation (IG-IMRT) With Cetuximab for Locoregionally Confined Recurrent Head and Neck Squamous Cell Carcinoma
Showing all 4 trials